Therapy-recalcitrant folliculitis decalvans controlled successfully with adalimumab

We present the therapy-recalcitrant case of FD which is controlled successfully by subcutaneous injections of Adalimumab (Humira®) with no serious adverse events throughout the treatment.

Source: International Journal of Trichology - January 13, 2020 Category: Dermatology Authors: Meshal M Alhameedy Adel M Alsantali Source Type: research